Publications

Filters: Author is Fox, L E  [Clear All Filters]
2000
Fox LE, Rosenthal RC, King RR, Levine PB, Vail DM, Helfand SC, MacEwen EG, Perez-Soler R, Calderwood-Mays M, Kurzman ID.  2000.  Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.. American journal of veterinary research. 61(7):791-5. Abstract
1995
Fox LE, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Vail DM, Kisseberth W, London C, Madewell BR, Rodriguez CO.  1995.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study.. Cancer biotherapy. 10(2):125-30. Abstract
Kurzman ID, MacEwen EG, Rosenthal RC, Fox LE, Keller ET, Helfand SC, Vail DM, Dubielzig RR, Madewell BR, Rodriguez CO.  1995.  Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12):1595-601. Abstract
1993
Keller ET, MacEwen EG, Rosenthal RC, Helfand SC, Fox LE.  1993.  Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 7(5):289-95. Abstract